Francesca Giuntini

Francesca Giuntini

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
RCRoberto Canaparo
Roberto Canaparo
FFFederica Foglietta
Federica Foglietta
FGFrancesca Giuntini
Francesca Giuntini
CPCarlo Della Pepa
Carlo Della Pepa
Franco DosioFranco Dosio
Franco Dosio
LSLoredana Serpe
Loredana Serpe
Conventional drugs used for antibacterial therapy display several limitations. This is not due to antibiotics being ineffective, but rather due to their low bioavailability, limited penetration to sites of infection and the rise of drug-resistant bacteria. Although new delivery systems (e.g., nanoparticles) that are loaded with antibacterial drugs have been designed to overcome these limitations, therapeutic efficacy does not seem to have improved. Against this backdrop, stimuli-responsive antibiotic-loaded nanoparticles and materials with antimicrobial properties (nanoantibiotics) present the ability to enhance therapeutic efficacy, while also reducing drug resistance and side effects. These stimuli can either be exogenous (e.g., light, ultrasound) or endogenous (e.g., pH, variation in redox gradient, enzymes). This promising therapeutic approach relies on advances in materials science and increased knowledge of microorganism growth and biofilm formation. This review provides an overview in the field of antibacterial drug-delivery systems and nanoantibiotics that benefit from a response to specific triggers, and also presents a number of future prospects.

1 September 2015 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
LSLoredana Serpe
Loredana Serpe
FGFrancesca Giuntini
Francesca Giuntini

2 February 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
RRRubén Ruiz‐González
Rubén Ruiz‐González
RBRoger Bresolí‐Obach
Roger Bresolí‐Obach
ÒGÒscar Gulías
Òscar Gulías
MAMontserrat Agut
Montserrat Agut
HSHuguette Savoie
Huguette Savoie
FGFrancesca Giuntini
Francesca Giuntini

18 March 2011 in Biochemistry
Verified
Journal Article
Closed access
CWClaire Webb
Claire Webb
AUAbhishek Upadhyay
Abhishek Upadhyay
FGFrancesca Giuntini
Francesca Giuntini
IEIan Michael Eggleston
Ian Michael Eggleston
MFMakoto Furutani-Seiki
Makoto Furutani-Seiki
SBStefan Bagby
Stefan Bagby

1 June 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
FGFrancesca Giuntini
Francesca Giuntini
FFFederica Foglietta
Federica Foglietta
AMArianna M. Marucco
Arianna M. Marucco
ATAdriano Troia
Adriano Troia
NDNikolai V. Dezhkunov
Nikolai V. Dezhkunov
RCRoberto Canaparo
Roberto Canaparo

1 April 2011 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
FGFrancesca Giuntini
Francesca Giuntini
CACristina M. A. Alonso
Cristina M. A. Alonso
RBRoss W. Boyle
Ross W. Boyle
The association of photosensitisers to peptides and proteins is a recognised and successful method for enhancing the selectivity and efficacy of photodynamic treatment. The covalent attachment of porphyrins and related macrocycles to peptides and proteins can generate new phototoxic species that allow the concentration of the oxidative damage to the target area, thanks to their enhanced cellular uptake, favourable sub-cellular distribution, and ability to target receptors or enzymes over-expressed by a given tissue or cell. The need to exert control over the regioselectivity of the conjugation led to the exploration of a variety of chemistries; in some cases based on bioorthogonal ligations, in others exploring the reactivity of naturally occurring functional groups. In this review we place a major emphasis on the synthetic strategies adopted to generate such conjugates. All such strategies will be surveyed, together with the methods used to introduce or unmask the appropriate reactive functionalities both on the peptide moiety and the photosensitiser.